Janusil-O Oral Suspension Sugar Free is a combination antacid formulation containing Magaldrate 400mg, Simethicone 20mg, and Oxetacaine 10mg per 5ml. Magaldrate acts as a fast-acting antacid that neutralizes gastric acid, providing symptomatic relief from hyperacidity, heartburn, and indigestion. Simethicone serves as an anti-foaming agent, reducing bloating and discomfort caused by excessive gas by facilitating the coalescence and expulsion of gas bubbles from the gastrointestinal tract. Oxetacaine is a local anesthetic that provides rapid analgesic effect by numbing the mucosal lining of the esophagus and stomach, thereby alleviating pain and discomfort associated with acid reflux, gastritis, and esophagitis. The sugar-free oral suspension formulation is suitable for patients requiring sugar restriction, including diabetics. Janusil-O is indicated for the symptomatic treatment of acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and functional dyspepsia. It is generally well tolerated; however, caution is advised in patients with renal impairment due to magnesium content. The suspension should be administered as directed by a healthcare professional, typically after meals and at bedtime, to optimize acid neutralization and symptom control.